vs

Side-by-side financial comparison of EXPONENT INC (EXPO) and ICHOR HOLDINGS, LTD. (ICHR). Click either name above to swap in a different company.

ICHOR HOLDINGS, LTD. is the larger business by last-quarter revenue ($256.1M vs $166.3M, roughly 1.5× EXPONENT INC). EXPONENT INC runs the higher net margin — 17.8% vs -1.0%, a 18.7% gap on every dollar of revenue. On growth, EXPONENT INC posted the faster year-over-year revenue change (14.3% vs 4.7%). Over the past eight quarters, ICHOR HOLDINGS, LTD.'s revenue compounded faster (12.3% CAGR vs 8.8%).

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

Ichor Holdings Ltd. designs, manufactures and supplies critical fluid delivery systems, subsystems and related components for the global semiconductor manufacturing sector. Its products are integrated into front-end wafer processing equipment, supporting production of advanced logic, memory and specialty chips for leading semiconductor device and equipment makers across North America, East Asia and Europe.

EXPO vs ICHR — Head-to-Head

Bigger by revenue
ICHR
ICHR
1.5× larger
ICHR
$256.1M
$166.3M
EXPO
Growing faster (revenue YoY)
EXPO
EXPO
+9.5% gap
EXPO
14.3%
4.7%
ICHR
Higher net margin
EXPO
EXPO
18.7% more per $
EXPO
17.8%
-1.0%
ICHR
Faster 2-yr revenue CAGR
ICHR
ICHR
Annualised
ICHR
12.3%
8.8%
EXPO

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
EXPO
EXPO
ICHR
ICHR
Revenue
$166.3M
$256.1M
Net Profit
$29.6M
$-2.5M
Gross Margin
12.6%
Operating Margin
24.9%
88.2%
Net Margin
17.8%
-1.0%
Revenue YoY
14.3%
4.7%
Net Profit YoY
11.0%
45.8%
EPS (diluted)
$0.59
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPO
EXPO
ICHR
ICHR
Q1 26
$166.3M
$256.1M
Q4 25
$147.1M
$223.6M
Q3 25
$142.0M
$239.3M
Q2 25
$145.5M
$240.3M
Q1 25
$136.8M
$244.5M
Q4 24
$233.3M
Q3 24
$136.3M
$211.1M
Q2 24
$140.5M
$203.2M
Net Profit
EXPO
EXPO
ICHR
ICHR
Q1 26
$29.6M
$-2.5M
Q4 25
$28.0M
$-16.0M
Q3 25
$26.6M
$-22.9M
Q2 25
$26.6M
$-9.4M
Q1 25
$23.6M
$-4.6M
Q4 24
$-3.9M
Q3 24
$26.0M
$-2.8M
Q2 24
$29.2M
$-5.1M
Gross Margin
EXPO
EXPO
ICHR
ICHR
Q1 26
12.6%
Q4 25
9.4%
Q3 25
4.6%
Q2 25
11.3%
Q1 25
11.7%
Q4 24
11.6%
Q3 24
13.2%
Q2 24
12.6%
Operating Margin
EXPO
EXPO
ICHR
ICHR
Q1 26
24.9%
88.2%
Q4 25
19.7%
-6.2%
Q3 25
12.1%
-8.1%
Q2 25
30.5%
-2.0%
Q1 25
19.9%
-0.5%
Q4 24
-0.5%
Q3 24
19.0%
-0.2%
Q2 24
25.4%
-1.1%
Net Margin
EXPO
EXPO
ICHR
ICHR
Q1 26
17.8%
-1.0%
Q4 25
19.1%
-7.1%
Q3 25
18.7%
-9.6%
Q2 25
18.3%
-3.9%
Q1 25
17.2%
-1.9%
Q4 24
-1.7%
Q3 24
19.1%
-1.3%
Q2 24
20.8%
-2.5%
EPS (diluted)
EXPO
EXPO
ICHR
ICHR
Q1 26
$0.59
$-0.07
Q4 25
$0.55
$-0.46
Q3 25
$0.52
$-0.67
Q2 25
$0.52
$-0.28
Q1 25
$0.45
$-0.13
Q4 24
$-0.11
Q3 24
$0.50
$-0.08
Q2 24
$0.57
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPO
EXPO
ICHR
ICHR
Cash + ST InvestmentsLiquidity on hand
$118.6M
$89.1M
Total DebtLower is stronger
$6.3M
Stockholders' EquityBook value
$338.3M
$668.0M
Total Assets
$687.4M
$972.5M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPO
EXPO
ICHR
ICHR
Q1 26
$118.6M
$89.1M
Q4 25
$207.4M
$98.3M
Q3 25
$231.8M
$92.5M
Q2 25
$245.1M
$92.2M
Q1 25
$258.9M
$109.3M
Q4 24
$108.7M
Q3 24
$219.7M
$116.4M
Q2 24
$203.3M
$114.3M
Total Debt
EXPO
EXPO
ICHR
ICHR
Q1 26
$6.3M
Q4 25
$123.5M
Q3 25
$123.5M
Q2 25
$125.0M
Q1 25
$126.8M
Q4 24
$128.5M
Q3 24
$130.3M
Q2 24
$130.2M
Stockholders' Equity
EXPO
EXPO
ICHR
ICHR
Q1 26
$338.3M
$668.0M
Q4 25
$402.9M
$663.9M
Q3 25
$427.8M
$676.2M
Q2 25
$441.4M
$694.1M
Q1 25
$421.1M
$700.4M
Q4 24
$698.3M
Q3 24
$410.3M
$697.3M
Q2 24
$393.2M
$694.9M
Total Assets
EXPO
EXPO
ICHR
ICHR
Q1 26
$687.4M
$972.5M
Q4 25
$761.4M
$942.9M
Q3 25
$759.4M
$966.6M
Q2 25
$763.2M
$985.1M
Q1 25
$777.3M
$1.0B
Q4 24
$995.6M
Q3 24
$744.1M
$975.9M
Q2 24
$709.2M
$947.7M
Debt / Equity
EXPO
EXPO
ICHR
ICHR
Q1 26
0.01×
Q4 25
0.19×
Q3 25
0.18×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.19×
Q2 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPO
EXPO
ICHR
ICHR
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-10.0M
FCF MarginFCF / Revenue
-3.9%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPO
EXPO
ICHR
ICHR
Q1 26
Q4 25
$32.7M
$9.2M
Q3 25
$36.2M
$9.2M
Q2 25
$7.3M
$-7.5M
Q1 25
$56.1M
$19.0M
Q4 24
$-2.5M
Q3 24
$29.7M
$8.1M
Q2 24
$48.3M
$17.5M
Free Cash Flow
EXPO
EXPO
ICHR
ICHR
Q1 26
$-10.0M
Q4 25
$30.0M
$5.9M
Q3 25
$33.9M
$2.1M
Q2 25
$5.5M
$-14.8M
Q1 25
$53.5M
$496.0K
Q4 24
$-6.9M
Q3 24
$28.0M
$2.2M
Q2 24
$47.2M
$14.6M
FCF Margin
EXPO
EXPO
ICHR
ICHR
Q1 26
-3.9%
Q4 25
20.4%
2.6%
Q3 25
23.9%
0.9%
Q2 25
3.8%
-6.2%
Q1 25
39.1%
0.2%
Q4 24
-3.0%
Q3 24
20.5%
1.0%
Q2 24
33.6%
7.2%
Capex Intensity
EXPO
EXPO
ICHR
ICHR
Q1 26
2.8%
Q4 25
1.8%
1.5%
Q3 25
1.6%
3.0%
Q2 25
1.2%
3.0%
Q1 25
1.9%
7.6%
Q4 24
1.9%
Q3 24
1.3%
2.8%
Q2 24
0.8%
1.4%
Cash Conversion
EXPO
EXPO
ICHR
ICHR
Q1 26
Q4 25
1.16×
Q3 25
1.36×
Q2 25
0.27×
Q1 25
2.38×
Q4 24
Q3 24
1.14×
Q2 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

ICHR
ICHR

Segment breakdown not available.

Related Comparisons